Operating Income (Loss) in USD of CAPRICOR THERAPEUTICS, INC. from Q2 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
CAPRICOR THERAPEUTICS, INC. quarterly/annual Operating Income (Loss) history and change rate from Q2 2010 to Q3 2025.
  • CAPRICOR THERAPEUTICS, INC. Operating Income (Loss) for the quarter ending 30 Sep 2025 was -$26.3M, a 102% decline year-over-year.
  • CAPRICOR THERAPEUTICS, INC. Operating Income (Loss) for the twelve months ending 30 Sep 2025 was -$86.7M, a 140% decline year-over-year.
  • CAPRICOR THERAPEUTICS, INC. annual Operating Income (Loss) for 2024 was -$42.6M, a 76.8% decline from 2023.
  • CAPRICOR THERAPEUTICS, INC. annual Operating Income (Loss) for 2023 was -$24.1M, a 18.9% increase from 2022.
  • CAPRICOR THERAPEUTICS, INC. annual Operating Income (Loss) for 2022 was -$29.7M, a 41.8% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

CAPRICOR THERAPEUTICS, INC. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$86.7M -$26.3M -$13.3M -102% 01 Jul 2025 30 Sep 2025 10-Q 10 Nov 2025
Q2 2025 -$73.4M -$27.7M -$16.1M -139% 01 Apr 2025 30 Jun 2025 10-Q 11 Aug 2025
Q1 2025 -$57.3M -$25M -$14.7M -143% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025
Q4 2024 -$42.6M -$7.7M -$6.42M -501% 01 Oct 2024 31 Dec 2024 10-K 26 Mar 2025
Q3 2024 -$36.1M -$13M -$6.15M -89.5% 01 Jul 2024 30 Sep 2024 10-Q 10 Nov 2025
Q2 2024 -$30M -$11.6M -$3.84M -49.6% 01 Apr 2024 30 Jun 2024 10-Q 11 Aug 2025
Q1 2024 -$26.2M -$10.3M -$2.08M -25.4% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025
Q4 2023 -$24.1M -$1.28M +$6.79M +84.1% 01 Oct 2023 31 Dec 2023 10-K 26 Mar 2025
Q3 2023 -$30.9M -$6.86M -$387K -5.97% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024
Q2 2023 -$30.5M -$7.75M -$426K -5.81% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024
Q1 2023 -$30.1M -$8.18M -$353K -4.51% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024
Q4 2022 -$29.7M -$8.07M -$1.69M -26.4% 01 Oct 2022 31 Dec 2022 10-K 11 Mar 2024
Q3 2022 -$28M -$6.48M -$2.16M -50.1% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023
Q2 2022 -$25.8M -$7.32M -$2.24M -44% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023
Q1 2022 -$23.6M -$7.83M -$2.67M -51.7% 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023
Q4 2021 -$20.9M -$6.38M -$2.2M -52.6% 01 Oct 2021 31 Dec 2021 10-K 17 Mar 2023
Q3 2021 -$18.7M -$4.31M -$400K -10.2% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022
Q2 2021 -$18.3M -$5.08M -$1.6M -45.7% 01 Apr 2021 30 Jun 2021 10-Q 12 Aug 2022
Q1 2021 -$16.7M -$5.16M -$3.05M -145% 01 Jan 2021 31 Mar 2021 10-Q 11 May 2022
Q4 2020 -$13.7M -$4.18M -$2.7M -182% 01 Oct 2020 31 Dec 2020 10-K 11 Mar 2022
Q3 2020 -$11M -$3.91M -$2.29M -140% 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021
Q2 2020 -$8.71M -$3.49M -$1.42M -68.8% 01 Apr 2020 30 Jun 2020 10-Q 13 Aug 2021
Q1 2020 -$7.28M -$2.11M +$450K +17.6% 01 Jan 2020 31 Mar 2020 10-Q 14 May 2021
Q4 2019 -$7.73M -$1.48M +$1.82M +55.1% 01 Oct 2019 31 Dec 2019 10-K 15 Mar 2021
Q3 2019 -$9.56M -$1.63M +$2.54M +61% 01 Jul 2019 30 Sep 2019 10-Q 13 Nov 2020
Q2 2019 -$12.1M -$2.07M +$2.1M +50.4% 01 Apr 2019 30 Jun 2019 10-Q 10 Aug 2020
Q1 2019 -$14.2M -$2.56M +$1.13M +30.6% 01 Jan 2019 31 Mar 2019 10-Q 15 May 2020
Q4 2018 -$15.3M -$3.31M -$25.5K -0.78% 01 Oct 2018 31 Dec 2018 10-K 27 Mar 2020
Q3 2018 -$15.3M -$4.17M -$1.53M -58.2% 01 Jul 2018 30 Sep 2018 10-Q 08 Nov 2019
Q2 2018 -$13.8M -$4.16M -$784K -23.2% 01 Apr 2018 30 Jun 2018 10-Q 08 Aug 2019
Q1 2018 -$13M -$3.69M -$121K -3.38% 01 Jan 2018 31 Mar 2018 10-Q 14 May 2019
Q4 2017 -$12.9M -$3.28M -$367K -12.6% 01 Oct 2017 31 Dec 2017 10-K 29 Mar 2019
Q3 2017 -$12.5M -$2.64M +$2.6M +49.7% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018
Q2 2017 -$15.1M -$3.38M +$1.23M +26.7% 01 Apr 2017 30 Jun 2017 10-Q 13 Aug 2018
Q1 2017 -$16.3M -$3.57M +$645K +15.3% 01 Jan 2017 31 Mar 2017 10-Q 14 May 2018
Q4 2016 -$17M -$2.91M +$372K +11.3% 01 Oct 2016 31 Dec 2016 10-K 22 Mar 2018
Q3 2016 -$17.3M -$5.24M -$2.39M -83.8% 01 Jul 2016 30 Sep 2016 10-Q 14 Nov 2017
Q2 2016 -$15M -$4.61M -$1.55M -50.7% 01 Apr 2016 30 Jun 2016 10-Q 14 Aug 2017
Q1 2016 -$13.4M -$4.21M -$796K -23.3% 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017
Q4 2015 -$12.6M -$3.28M -$1.42M -75.9% 01 Oct 2015 31 Dec 2015 10-K 16 Mar 2017
Q3 2015 -$11.2M -$2.85M -$1.37M -91.9% 01 Jul 2015 30 Sep 2015 10-Q 14 Nov 2016
Q2 2015 -$9.83M -$3.06M -$1.58M -107% 01 Apr 2015 30 Jun 2015 10-Q 15 Aug 2016
Q1 2015 -$8.25M -$3.41M -$2.23M -188% 01 Jan 2015 31 Mar 2015 10-Q 13 May 2016
Q4 2014 -$6.02M -$1.87M +$494K +20.9% 01 Oct 2014 31 Dec 2014 10-K 30 Mar 2016
Q3 2014 -$6.51M -$1.49M +$8.96K +0.6% 01 Jul 2014 30 Sep 2014 10-Q 13 Nov 2015
Q2 2014 -$6.52M -$1.48M +$135K +8.34% 01 Apr 2014 30 Jun 2014 10-Q 14 Aug 2015
Q1 2014 -$6.66M -$1.19M +$247K +17.2% 01 Jan 2014 31 Mar 2014 10-Q 13 May 2015
Q4 2013 -$6.9M -$2.36M -$2.38M -11583% 01 Oct 2013 31 Dec 2013 10-K 16 Mar 2015
Q3 2013 -$4.52M -$1.49M -$918K -159% 01 Jul 2013 30 Sep 2013 10-Q 14 Nov 2014
Q2 2013 -$3.6M -$1.62M -$841K -109% 01 Apr 2013 30 Jun 2013 10-Q 14 Aug 2014
Q1 2013 -$2.76M -$1.43M -$662K -86% 01 Jan 2013 31 Mar 2013 10-Q 15 May 2014
Q4 2012 -$2.1M $20.6K +$1.69M 01 Oct 2012 31 Dec 2012 10-K 31 Mar 2014
Q3 2012 -$3.79M -$576K +$580K +50.2% 01 Jul 2012 30 Sep 2012 10-Q 14 Nov 2013
Q2 2012 -$4.37M -$774K +$106K +12% 01 Apr 2012 30 Jun 2012 10-Q 14 Aug 2013
Q1 2012 -$4.47M -$770K +$428K +35.7% 01 Jan 2012 31 Mar 2012 10-Q 21 Jun 2013
Q4 2011 -$4.9M -$1.66M 01 Oct 2011 31 Dec 2011 10-K 21 Jun 2013
Q3 2011 -$1.16M +$656K +36.2% 01 Jul 2011 30 Sep 2011 10-Q 21 Jun 2013
Q2 2011 -$880K +$621K +41.4% 01 Apr 2011 30 Jun 2011 10-Q/A 10 Sep 2012
Q1 2011 -$1.2M 01 Jan 2011 31 Mar 2011 10-Q/A 15 May 2012
Q3 2010 -$1.81M 01 Jul 2010 30 Sep 2010 10-Q 14 Nov 2011
Q2 2010 -$1.5M 01 Apr 2010 30 Jun 2010 10-Q 15 Aug 2011

CAPRICOR THERAPEUTICS, INC. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$42.6M -$18.5M -76.8% 01 Jan 2024 31 Dec 2024 10-K 26 Mar 2025
2023 -$24.1M +$5.62M +18.9% 01 Jan 2023 31 Dec 2023 10-K 26 Mar 2025
2022 -$29.7M -$8.76M -41.8% 01 Jan 2022 31 Dec 2022 10-K 11 Mar 2024
2021 -$20.9M -$7.25M -52.9% 01 Jan 2021 31 Dec 2021 10-K 17 Mar 2023
2020 -$13.7M -$5.96M -77% 01 Jan 2020 31 Dec 2020 10-K 11 Mar 2022
2019 -$7.73M +$7.59M +49.5% 01 Jan 2019 31 Dec 2019 10-K 15 Mar 2021
2018 -$15.3M -$2.46M -19.2% 01 Jan 2018 31 Dec 2018 10-K 27 Mar 2020
2017 -$12.9M +$4.11M +24.2% 01 Jan 2017 31 Dec 2017 10-K 29 Mar 2019
2016 -$17M -$4.36M -34.6% 01 Jan 2016 31 Dec 2016 10-K 22 Mar 2018
2015 -$12.6M -$6.59M -110% 01 Jan 2015 31 Dec 2015 10-K 16 Mar 2017
2014 -$6.02M +$885K +12.8% 01 Jan 2014 31 Dec 2014 10-K 30 Mar 2016
2013 -$6.9M -$4.8M -229% 01 Jan 2013 31 Dec 2013 10-K 16 Mar 2015
2012 -$2.1M +$2.8M +57.1% 01 Jan 2012 31 Dec 2012 10-K 31 Mar 2014
2011 -$4.9M +$1.39M +22.2% 01 Jan 2011 31 Dec 2011 10-K 21 Jun 2013
2010 -$6.29M 01 Jan 2010 31 Dec 2010 10-K 02 Apr 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.